MabTrix

MabTrix is a preclinical-stage biopharmaceutical company developing a function-blocking therapeutic monoclonal antibody (MAb) for inflammatory bowel disease (IBD) or an orphan form as initial indication. MabTrix aims to develop a novel humanized MAb tha...